Cardiovascular Diabetology

Cardiovascular Diabetology(英文缩写 CARDIOVASC DIABETOL),ISSN 1475-2840,eISSN 1475-2840 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

2026 年数据 · 影响因子
15.600
JCR 分区
Q1
CAS 分区
B1
近一年发文量
0

指标来源:jcr_cas_ifqb

ISSN: 1475-2840 · eISSN: 1475-2840 · 缩写: CARDIOVASC DIABETOL

期刊简介

暂无简介。

Cardiovascular Diabetology 最新收录文献

※ 中文译文由 AI 辅助生成,仅供学术参考,请以英文原文为准。

  1. Retraction Note to: Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice.
    查看详情 DOI
  2. Epigenetic and genetic factors modifying the association between diet quality and incident type 2 diabetes: the EPIC-Potsdam cohort.

    Benefits of healthy diets for type 2 diabetes (T2D) prevention are established. It remains unclear whether such recommendations should be tailored to specific subgroups according to their susceptibili…

    查看详情 DOI
  3. Evaluative performance of triglyceride-glucose-frailty index versus surrogate insulin resistance indices for advanced cardiovascular-kidney-metabolic syndrome, cardiometabolic multimorbidity, and mortality: the role of estimated glomerular filtration rate.

    Cardiovascular-kidney-metabolic (CKM) syndrome and cardiometabolic multimorbidity (CMM) carry substantial mortality, yet whether a composite index integrating insulin resistance and frailty shows stro…

    查看详情 DOI
  4. Composite C-reactive protein-triglyceride-glucose adiposity indices and incident cardiovascular-liver-metabolic multimorbidity: a prospective cohort study. 复合C-反应蛋白甘油三酯葡萄糖肥胖指数和心血管-肝脏代谢多发病率:一项前瞻性队列研究

    The C-reactive protein-triglyceride-glucose index (CTI) is a comprehensive marker that reflects inflammation and insulin resistance. Cardiovascular-liver-metabolic (CLM) diseases caused by multiple fa…

    查看详情 DOI
  5. Disease-modifying anti-diabetic drugs (DMADDs): bridging the SIMPLE approach to disease interception.

    The traditional glucose-centric paradigm of type 2 diabetes management is being superseded by growing evidence that certain agents, sodium-glucose cotransporter-2 inhibitors (SGLT2i), glucagon-like pe…

    查看详情 DOI
  6. Composite metabolic biomarkers for cardiovascular risk assessment in CKM syndrome.
    查看详情 DOI
  7. Clarifying the role of TyG-VLR in CKM risk characterization: Reply to "Composite metabolic biomarkers for cardiovascular risk assessment in CKM syndrome".
    查看详情 DOI
  8. Excess risk of cardiovascular disease and mortality after amputation in type 2 diabetes: a nationwide population study from the Swedish National Diabetes Register.

    Individuals with diabetes are prone to peripheral angiopathy and neuropathy, predisposing them to diabetic foot ulcers and, ultimately, lower-extremity amputation. The long-term cardiovascular impact …

    查看详情 DOI
  9. The cholesterol, high-density lipoprotein, and glucose index and its derived indices predict cardiometabolic multimorbidity development and progression in metabolic dysfunction-associated steatotic liver disease individuals: a prospective cohort study.

    Dysregulation of cholesterol, high-density lipoprotein cholesterol, and glucose metabolism is thought to be an important metabolic link between metabolic dysfunction-associated steatotic liver disease…

    查看详情 DOI
  10. A cardiometabolic perspective on post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID.

    Post-exertional malaise (PEM), the defining feature of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), is increasingly recognized in individuals with Long COVID. Although traditionally vi…

    查看详情 DOI

在 Cardiovascular Diabetology 中搜索更多文献

支持中英文检索 · 智能翻译 · 影响因子 · PDF 下载 · AI 文献阅读

指标接近的期刊